Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
Massachusetts General Hospital
Stanford University
Corvus Pharmaceuticals, Inc.
Eastern Cooperative Oncology Group
Case Comprehensive Cancer Center
Institut Bergonié
University of Washington
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
INSYS Therapeutics Inc
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Case Comprehensive Cancer Center